Stay updated on Tabelecleucel & Pembrolizumab in EBV+ NPC Clinical Trial
Sign up to get notified when there's something new on the Tabelecleucel & Pembrolizumab in EBV+ NPC Clinical Trial page.

Latest updates to the Tabelecleucel & Pembrolizumab in EBV+ NPC Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, indicating a software version update for the site. This change does not modify the displayed study content or its results.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page’s revision/version label was updated from v3.5.2 to v3.5.3, indicating a change to the site build rather than the clinical trial information shown to users.SummaryDifference0.0%

- Check38 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check53 days agoChange DetectedPosted trial results and updated study record dates were added to the page (Results First Posted 2024-11-14; Study Record Dates Updated 2024-11-14).SummaryDifference0.0%

- Check60 days agoChange DetectedResults data was added to the study page, including a 'Results First Posted' date (2024-11-14). Study record dates were updated accordingly.SummaryDifference0.0%

- Check67 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Tabelecleucel & Pembrolizumab in EBV+ NPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tabelecleucel & Pembrolizumab in EBV+ NPC Clinical Trial page.